These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 11248785)
1. Glycoprotein IIb/IIIa Inhibition as an adjunct to rescue angioplasty after failed fibrinolysis. Sallach JA; Greenbaum AB J Thromb Thrombolysis; 2001 Feb; 11(1):5-9. PubMed ID: 11248785 [No Abstract] [Full Text] [Related]
2. Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction. Ronner E; van Domburg RT; van den Brand MJ; de Feyter PJ; Foley DP; van der Giessen WJ; Serruys PW; Simoons ML Eur Heart J; 2002 Oct; 23(19):1529-37. PubMed ID: 12242073 [TBL] [Abstract][Full Text] [Related]
3. GP IIB/IIIA blockers with and without thrombolytic agent in prehospital treatment of acute myocardial infarction. Verheugt FW Thromb Res; 2001 Sep; 103 Suppl 1():S113-6. PubMed ID: 11567678 [TBL] [Abstract][Full Text] [Related]
4. Overview of the use of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction. Joseph A J Emerg Med; 1999; 17(3):567-73. PubMed ID: 10338258 [No Abstract] [Full Text] [Related]
5. Glycoprotein IIb/IIIa inhibitors during rescue percutaneous coronary intervention in acute myocardial infarction. Gruberg L; Suleiman M; Kapeliovich M; Hammerman H; Grenadier E; Boulus M; Amikam S; Markiewicz W; Beyar R J Invasive Cardiol; 2006 Feb; 18(2):59-62. PubMed ID: 16446517 [TBL] [Abstract][Full Text] [Related]
6. Platelet GPIIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies. Mahadevan VS; McCarty D; Adgey AA Eur Heart J; 2002 Oct; 23(19):1490-1. PubMed ID: 12242068 [No Abstract] [Full Text] [Related]
7. Coronary stenting and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction. Santoro GM; Bolognese L Am Heart J; 2001 Feb; 141(2 Suppl):S26-35. PubMed ID: 11174356 [TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of abciximab in patients with acute myocardial infarction and failed thrombolysis. Di Pasquale P; Cannizzaro S; Scalzo S; Maringhini G; Vitrano GM; Giubilato A; Giambanco F; Sarullo FM; Paterna S Int J Cardiol; 2003 Dec; 92(2-3):265-70. PubMed ID: 14659863 [TBL] [Abstract][Full Text] [Related]
9. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Pereira H; Rev Port Cardiol; 2001 Jun; 20(6):687-8. PubMed ID: 11525077 [No Abstract] [Full Text] [Related]
11. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study. Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719 [TBL] [Abstract][Full Text] [Related]
12. Reperfusion in acute myocardial infarction: current concepts. Katritsis D; Karvouni E; Webb-Peploe MM Prog Cardiovasc Dis; 2003; 45(6):481-92. PubMed ID: 12800129 [TBL] [Abstract][Full Text] [Related]
13. Glycoprotein IIb/IIIa antagonists: an attractive new approach to reperfusion in acute myocardial infarction. Gambhir DS Indian Heart J; 1999; 51(3):259-60, 309. PubMed ID: 10624062 [No Abstract] [Full Text] [Related]